ACCPL logo

Accretion Pharmaceuticals Limited Stock Price

NSEI:ACCPL Community·₹638.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ACCPL Share Price Performance

₹57.40
-25.55 (-30.80%)
₹57.40
-25.55 (-30.80%)
Price ₹57.40

ACCPL Community Narratives

There are no narratives available yet.

Recent ACCPL News & Updates

Accretion Pharmaceuticals Limited Key Details

₹573.8m

Revenue

₹400.2m

Cost of Revenue

₹173.5m

Gross Profit

₹105.6m

Other Expenses

₹67.9m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
6.11
Gross Margin
30.25%
Net Profit Margin
11.84%
Debt/Equity Ratio
92.3%

Accretion Pharmaceuticals Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Proven track record with adequate balance sheet.

2 Risks
2 Rewards

About ACCPL

Founded
2012
Employees
125
CEO
Vivek Ashok Patel
WebsiteView website
www.accretionpharma.com

Accretion Pharmaceuticals Limited engages in the manufacturing and marketing of pharmaceutical products in India. The company offers antibiotic, antibacterial, antifungal, anti-inflammatory, anti-spasmodic, antihistamine, antiallergy, anticough, anticold, antiulcer, gastrointestinal, antacid, anti-diabetic, cardiac, anti-hypertensive, psychotropic, memory enhancer, vitamins, supplements, and other products. It also provides external preparation, oral powder, effervescent formulation, and nutraceutical products, as well as formulations for brain and memory care, neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, GIT care, joint and bone care, immunity booster, gynec care, hair and skin care, nail care, and infertility, and PCOS care. The company offers its products in the form of tablets, capsules, oral liquid, ointment, cream, gel, lotion, medicated shampoo, mouthwash, dusting powder, sachet, and dry syrup through contract manufacturing and direct sales channels. It also exports its products to Africa, South-East Asia, and Latin America. Accretion Pharmaceuticals Limited was incorporated in 2012 and is based in Ahmedabad, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. In contrast, the market has seen a decline of 4.7% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›